Caplin Point Laboratories Limited (NSE:CAPLIPOINT)
India
· Delayed Price · Currency is INR 2,003.50
+59.10 (3.04%)
May 13, 2025, 3:30 PM IST
Caplin Point Laboratories Market Cap
Caplin Point Laboratories has a market cap or net worth of 147.72 billion as of May 13, 2025. Its market cap has increased by 45.79% in one year.
Market Cap
147.72B
Enterprise Value
140.54B
Revenue
18.90B
Ranking
n/a
PE Ratio
28.66
Stock Price
2,003.50
Market Cap Chart
Since February 26, 2002, Caplin Point Laboratories's market cap has increased from 5.60M to 147.72B, an increase of 2,638,180.58%. That is a compound annual growth rate of 55.01%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4,186.36B |
| Divi's Laboratories | 1,599.58B |
| Cipla | 1,195.31B |
| Mankind Pharma | 993.57B |
| Apollo Hospitals Enterprise | 966.52B |
| Zydus Lifesciences | 884.13B |
| Aurobindo Pharma | 676.29B |
| Alkem Laboratories | 591.43B |